A FRAX® model for the assessment of fracture probability in Belgium

The diagnosis of osteoporosis

(2010) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAX® and its applications to clinical practice

(2009) John A. Kanis et al.   BONE

BMD, clinical risk factors and their combination for hip fracture prevention

(2009) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women

(2008) Mickaël Hiligsmann et al.   BONE

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)

(2008) S. Fujiwara et al.   OSTEOPOROSIS INTERNATIONAL

Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study

(2008) E. V. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks

(2008) N. D. Nguyen et al.   OSTEOPOROSIS INTERNATIONAL

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

(2008) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

A reference standard for the description of osteoporosis

(2007) John A. Kanis et al.   BONE